Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan
- PMID: 8172612
- PMCID: PMC1138300
- DOI: 10.1042/bj2990507
Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan
Abstract
Rat peritoneal mast cells were shown to inactivate thrombin rapidly. The thrombin-inactivating activity was purified to homogeneity by a combination of anion-exchange chromatography and h.p.l.c. on a Superdex 75 column. The purified thrombin inactivator had an apparent molecular mass of 29 kDa and an N-terminal amino acid sequence identical to rat mast-cell protease 1 (RMCP-1). After labelling of the mast cells in vivo with 35SO4(2-), RMCP-1 was recovered in a macromolecular complex with [35S]heparin proteoglycans. Dissociation of RMCP-1 from the heparin proteoglycans by Superdex 75 chromatography in the presence of 2 M NaCl resulted in a marked loss of the thrombin-inactivating activity displayed by the enzyme. When RMCP-1 was reconstituted with either endogenous [35S]heparin proteoglycans or standard pig mucosal heparin, the enzyme regained its thrombin-inactivating properties. Affinity chromatography of endogenous [35S]heparin on matrix-linked RMCP-1 demonstrated that all of the heparin molecules contained high-affinity binding sites for the mast-cell protease. In contrast, the endogenous mast-cell heparin showed low affinity for antithrombin, a protease inhibitor involved in the regulation of coagulation enzymes.
Similar articles
-
Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.Eur J Biochem. 1995 Oct 1;233(1):192-9. doi: 10.1111/j.1432-1033.1995.192_1.x. Eur J Biochem. 1995. PMID: 7588746
-
Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.Biochem J. 1996 Dec 15;320 ( Pt 3)(Pt 3):897-903. doi: 10.1042/bj3200897. Biochem J. 1996. PMID: 9003378 Free PMC article.
-
Inhibition of rat mast cell protease 1 by vitronectin.FEBS Lett. 1994 Jun 13;346(2-3):189-93. doi: 10.1016/0014-5793(94)00465-x. FEBS Lett. 1994. PMID: 7516895
-
Mucosal mast cells in the rat and in man.Int Arch Allergy Appl Immunol. 1987;82(3-4):249-55. doi: 10.1159/000234199. Int Arch Allergy Appl Immunol. 1987. PMID: 2437041 Review.
-
Regulation of the gene that encodes the peptide core of heparin proteoglycan and other proteoglycans that are stored in the secretory granules of hematopoietic cells.Adv Exp Med Biol. 1992;313:59-67. doi: 10.1007/978-1-4899-2444-5_6. Adv Exp Med Biol. 1992. PMID: 1442270 Review. No abstract available.
Cited by
-
Tracing the Origins of IgE, Mast Cells, and Allergies by Studies of Wild Animals.Front Immunol. 2017 Dec 19;8:1749. doi: 10.3389/fimmu.2017.01749. eCollection 2017. Front Immunol. 2017. PMID: 29312297 Free PMC article. Review.
-
Cloning of the cDNAs for mast-cell chymases from the jejunum of Mongolian gerbils, Meriones unguiculatus, and their sequence similarities with chymases expressed in the connective-tissue mast cells of mice and rats.Biochem J. 1996 Mar 15;314 ( Pt 3)(Pt 3):923-9. doi: 10.1042/bj3140923. Biochem J. 1996. PMID: 8615790 Free PMC article.
-
Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.Glycoconj J. 1996 Feb;13(1):81-90. doi: 10.1007/BF01049683. Glycoconj J. 1996. PMID: 8785492
-
Immunological modulation of human cardiac mast cells.Neurochem Res. 1999 Sep;24(9):1195-202. doi: 10.1023/a:1020776807187. Neurochem Res. 1999. PMID: 10485592
-
Mast Cell and Basophil Granule Proteases - In Vivo Targets and Function.Front Immunol. 2022 Jul 5;13:918305. doi: 10.3389/fimmu.2022.918305. eCollection 2022. Front Immunol. 2022. PMID: 35865537 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical